Entries tagged with “Hikma Pharmaceuticals USA”
Executions
Feb 16, 2022
Deadline to Seek Execution of Zane Floyd Before Lethal-Injection Drugs Expire Passes in Nevada
Nevada prosecutors have failed to meet a deadline to obtain a death warrant to execute Zane Floyd before its supply of a key lethal-injection drug expires, indefinitely extending the near 16-year pause between executions in the state. With Nevada law requiring two-week notice of an execution, Clark County prosecutors had until February 13, 2022, to obtain a warrant if they were to attempt to execute Floyd before the state’s supply of 50 ketamine vials expires on February 28. They did not do…
Executions
Nov 09, 2021
Nevada Prosecutors Ask Federal Judge to Expedite Decision on Execution Protocol, Citing Looming Expiration Date of Questionably Obtained Drugs
Nevada prosecutors have asked a federal judge to expedite a decision on the constitutionality of the state’s execution process, saying accelerated review is necessary if the state is to execute Zane Floyd before its supply of a questionably obtained lethal-injection drug expires on February 28, 2022. On November 5, 2021, Chief Deputy Nevada Attorney General Randall Gilmer told U.S. District Court Judge Richard Boulware II that the state’s supply of the anesthetic ketamine, one of the drugs in…
Executions
Jun 29, 2021
Drug Manufacturer Says Nevada ‘Surreptitiously’ Obtained Drug for Execution in Violation of State and Federal Law
For the second time in three years, the Nevada Department of Corrections (NDOC) and the state of Nevada are facing legal action from a pharmaceutical manufacturer after obtaining drugs for an execution in violation of the drug manufacturer’s policies. Hikma Phamaceuticals, a maker of the anesthetic ketamine, sent a cease-and-desist letter to Nevada Attorney General Aaron Ford on June 24, 2021, threatening to sue the state for illegally obtaining ketamine for the execution of Zane Floyd, unless…
Issues
Jul 28, 2020
Nebraska Pharmacy May Have Violated Drug Distribution Policies, State Refused Drug Give-Back Demands, Records Show
Nebraska may have executed Carey Dean Moore in August 2018 using drugs supplied by a pharmacy in violation of pharmaceutical manufacturers’ distribution policies, Nebraska Department of Correctional Services (NDCS) records suggest. The records show that Community Pharmacy Services, a local pharmacy based in Greta, Nebraska, provided the state with supplies of five potential execution drugs. The distribution policies of the companies that produced the medicines prohibited their sale for use in…
Executions
Apr 07, 2020
News Brief — Drugmakers Drop Lawsuit as Nevada Returns Unused Execution Drugs
NEWS (4/7/20) — Nevada: A trial-court judge in Las Vegas has dismissed a lawsuit filed by drugmakers against the Nevada prison system after state officials agreed to return unused drugs it had obtained under false pretenses in a failed attempt to execute Scott Dozier in 2018. Pharmaceutical companies Alvogen, Inc., Hikma Pharmaceuticals USA, and Sandoz Inc. reached a settlement with the state in which Nevada agreed to give back the drugs, which have expired, in exchange for a refund of their…
Executions
Oct 01, 2018
Finding “Bad Faith,” Judge Grants Injunction Preventing Nevada From Using Drug in Execution
Finding that the Nevada Department of Corrections acted in “bad faith” to obtain the drug midazolam through “subterfuge,” a Las Vegas trial court has issued a preliminary injunction barring the state from using its supply of that drug in carrying out any execution. The 43-page ruling issued by Judge Elizabeth Gonzalez (pictured) on September 28, 2018 effectively freezes efforts by Nevada prosecutors to execute Scott Dozier, who has waived his appeals and asked to be put to death. Judge…
Executions
Aug 09, 2018
Drugmaker Sues Nebraska, as 15 Death-Penalty States Oppose Ruling Blocking Use of Drugs in Nevada
Less than a month after a Nevada court halted the execution of Scott Dozier in response to a lawsuit filed by generic-drug manufacturer Alvogen, another drug company has sued Nebraska, seeking to block the use of its medicines in an upcoming execution. The German-based pharmaceutical company Fresenius Kabi filed suit in Nebraska federal court on August 8, 2018 alleging that Nebraska intended to execute Carey Dean Moore on August 14 using drugs manufactured by the company that had been obtained…